Soleno Therapeutics, Inc. Common Stock
XNAS:SLNO
43.24
$43.31 - 30.00
$43.23 - 73.00
$42.8
$43.79
$43.5
$43.56
90.32
39.43
248448
1897527.1
49483184.13
Chart
TendieTensor AI Analysis
Company
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Fundamentals
133
-23.650000
4.727780
100
BBG0024L5B86
BBG0024L5B95
53.15M
53.71M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News